tiprankstipranks
Aurora Cannabis (ACB)
NASDAQ:ACB
US Market
ACB
Aurora Cannabis
RESEARCH TOOLSreports
Want to see ACB full AI Analyst Report?

Aurora Cannabis (ACB) Stock Forecast & Price Target

12,225 Followers
See the Price Targets and Ratings of:

ACB Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Aurora
Cannabis
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ACB Stock 12 Month Forecast

There Are No Analyst Ratings for ACB In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ACB Financial Forecast

ACB Earnings Forecast

Next quarter’s earnings estimate for ACB is -$0.04 with a range of -$0.19 to $0.07. The previous quarter’s EPS was $0.02. ACB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ACB has Performed in-line its overall industry.
Next quarter’s earnings estimate for ACB is -$0.04 with a range of -$0.19 to $0.07. The previous quarter’s EPS was $0.02. ACB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ACB has Performed in-line its overall industry.

ACB Sales Forecast

Next quarter’s sales forecast for ACB is $55.31M with a range of $49.89M to $60.42M. The previous quarter’s sales results were $68.82M. ACB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ACB has Performed in-line its overall industry.
Next quarter’s sales forecast for ACB is $55.31M with a range of $49.89M to $60.42M. The previous quarter’s sales results were $68.82M. ACB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ACB has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on ACB
Unknown Analyst
TD Cowen
Not Ranked
TD Cowen
$7.31
Buy
99.85%
Upside
Reiterated
02/05/26
Aurora Cannabis: Divestiture-Driven Margin Uplift and Improved Growth Outlook Support Buy Rating
ATB Cormark Capital Markets Analyst forecast on ACB
Frederico Gomes
ATB Cormark Capital Markets
ATB Cormark Capital Markets
$6.22
Buy
69.87%
Upside
Reiterated
02/05/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Canaccord Genuity Analyst forecast on ACB
Kenric Tyghe
Canaccord Genuity
Canaccord Genuity
$7.31→$6.58
Buy
79.86%
Upside
Reiterated
02/04/26
Aurora Cannabis price target lowered to C$9 from C$10 at CanaccordAurora Cannabis price target lowered to C$9 from C$10 at Canaccord
Roth MKM Analyst forecast on ACB
Bill Kirk
Roth MKM
Roth MKM
$4.39
Hold
19.91%
Upside
Reiterated
11/06/25
Roth MKM Reaffirms Their Hold Rating on Aurora Cannabis (ACB)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on ACB
Unknown Analyst
TD Cowen
Not Ranked
TD Cowen
$7.31
Buy
99.85%
Upside
Reiterated
02/05/26
Aurora Cannabis: Divestiture-Driven Margin Uplift and Improved Growth Outlook Support Buy Rating
ATB Cormark Capital Markets Analyst forecast on ACB
Frederico Gomes
ATB Cormark Capital Markets
ATB Cormark Capital Markets
$6.22
Buy
69.87%
Upside
Reiterated
02/05/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Canaccord Genuity Analyst forecast on ACB
Kenric Tyghe
Canaccord Genuity
Canaccord Genuity
$7.31→$6.58
Buy
79.86%
Upside
Reiterated
02/04/26
Aurora Cannabis price target lowered to C$9 from C$10 at CanaccordAurora Cannabis price target lowered to C$9 from C$10 at Canaccord
Roth MKM Analyst forecast on ACB
Bill Kirk
Roth MKM
Roth MKM
$4.39
Hold
19.91%
Upside
Reiterated
11/06/25
Roth MKM Reaffirms Their Hold Rating on Aurora Cannabis (ACB)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Aurora Cannabis

3 Months
xxx
Success Rate
3/3 ratings generated profit
100%
Average Return
+27.80%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +27.80% per trade.
1 Year
Frederico GomesATB Cormark Capital Markets
Success Rate
3/3 ratings generated profit
100%
Average Return
+43.27%
Copying Frederico Gomes's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +43.27% per trade.
2 Years
xxx
Success Rate
3/3 ratings generated profit
100%
Average Return
+43.27%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +43.27% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ACB Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
1
4
4
3
0
Buy
0
0
0
0
0
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
4
4
3
0
In the current month, ACB has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ACB average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

ACB Stock Forecast FAQ

What is ACB’s average 12-month price target, according to analysts?
Currently, no data Available
What is ACB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ACB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is ACB a Buy, Sell or Hold?
      Currently, no data Available
      What is Aurora Cannabis’s price target?
      Currently, no data Available
      What do analysts say about Aurora Cannabis?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of ACB?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.